Navigation Links
Albert Einstein Cancer Center begins 40th year of continuous NIH support with $17 million grant
Date:9/26/2013

September 26, 2013 (BRONX, NY) For the past four decades, scientists and clinicians at Albert Einstein Cancer Center (AECC) have made major contributions to research on many aspects of the cancer problem. With the recent renewal of the center's $16.7 million grant from the National Cancer Institute (NCI), AECC members will continue to investigate the underlying causes of cancer and new approaches to the prevention, diagnosis and treatment of these diseases.

"Our faculty is pleased and proud to have competed so favorably in the peer-review process that resulted in the renewal of this grant, particularly at a time of diminishing NCI support for cancer research," said I. David Goldman, M.D., director of AECC at Albert Einstein College of Medicine of Yeshiva University. Dr. Goldman is also professor of medicine and of molecular pharmacology and holds the Susan Resnick Fisher Chair at Einstein.

AECC was one of the first academic cancer research centers to receive an NCI designation, which it has held since 1972. Currently, there are 68 such centers throughout the United States. Since AECC's creation, its researchers have made notable fundamental scientific discoveries that have elucidated why cancers form, grow and spread. AECC's clinical scientists are developing novel approaches to cancer treatment and the center's epidemiologists are making major contributions to the understanding of the viral and other environmental causes of cancer and its prevention. AECC is a national resource for these studies given the diverse ethnic and racial populations in the Bronx.

This grant will provide continued support for five ongoing interdisciplinary research programs that form the basis of AECC's laboratory and translational work: tumor microenvironment and metastasis; stem cells, differentiation and cancer; experimental therapeutics; cancer epidemiology; and the biology of colon cancer. These research programs are supported by 14 specialized shared resource facilities that range from genomics and proteomics to biostatistics and bioinformatics. AECC also provides comprehensive support for, and oversight of, its clinical cancer research activities conducted at the Montefiore-Einstein Center for Cancer Care.


'/>"/>

Contact: Deirdre Branley
sciencenews@einstein.yu.edu
347-266-9204
Albert Einstein College of Medicine
Source:Eurekalert

Related medicine news :

1. UAlberta prostate cancer researcher and team developing homing beacon drugs to target cancer cells
2. UAlberta medical researchers make key discovery in fight against Alzheimers disease
3. UAlberta medical researchers discover new potential chemotherapy
4. Alternative medicine use high amoung children with chronic conditions: UAlberta medical research
5. Alternative medicine use high among children with chronic conditions: UAlberta medical research
6. New UAlberta research shows commonly prescribed medications could have adverse effects
7. UAlberta researcher pinpoints prescription for successful Primary Care Networks
8. Albertson & Davidson, LLP Obtains Court Order Requiring California Trustee to Provide Pre-Death Accounting
9. Dr. Anne Gershon receives 2013 Albert B. Sabin Gold Medal Award
10. Stadler Form’s Revolutionary Dehumidifier, Albert, Makes Its Debut at Humidifiers.com
11. DiscountFurnaceFilter.com Introduces the Latest Innovative Creation from Stadler Form, Albert the Dehumidifier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/4/2017)... SEOUL, South Korea , Oct. 4, 2017 /PRNewswire/ ... launched its next-generation CPR training aide "cprCUBE" on Kickstarter. ... of chest compression during cardiac arrests with better efficiency ... patient-mannequins. It also offers real-time feedback on efficacy of ... The crowdfunding campaign has a goal to raise ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
Breaking Medicine Technology: